Home h/c testing co grabs $2.5m
This article was originally published in Clinica
Executive Summary
BioIQ is looking to expand its product portfolio and commercialisation activities after closing a $2.5m series B financing. The round was led by Great Pacific Capital - the company's managing partner Dave Gross will become a director of BioQ, as part of the financing. Santa Barbara, California-based BioQ offers a series of home test kits for a number of chronic diseases including diabetes, cardiovascular and kidney diseases, colorectal and prostate cancers, thyroid disorders and osteoporosis. The test samples are then mailed to a central lab and users are able to access their results and relevant health information through an online BioQ account.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.